Clinical trial
Treatment of Beta-thalassemia Patients With Rapamycin (Sirolimus): From Pre-clinical Research to a Clinical Trial" - "Trattamento di Pazienti Con Beta-talassemia Con Rapamicina (Sirolimus): Dalla Ricerca Pre-clinica ad Uno Studio Clinico
NCT04247750 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Beta-thalassemia Patients With Rapamycin (Sirolimus): From Pre-clinical Research to a Clinical Trial" - "Trattamento di Pazienti Con Beta-talassemia Con Rapamicina (Sirolimus): Dalla Ricerca Pre-clinica ad Uno Studio Clinico
- Lead sponsor
- Università degli Studi di Ferrara
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 13, 2021
- Completion date
- April 30, 2022
- Enrollment
- 45 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.